Starsource Multitrade Limited - pharma in Kalyan, Maharashtra, India. FY 2026 financials & compliance.
CIN L46900MH1942PLC003556 Incorporated 17 August 1942 ROC Mumbai HQ Kalyan, Maharashtra, India
Active Listed - BSE: 506365 Public Limited Company pharma
Data last updated
Market Cap
₹17.10 Cr
STARSOURCE · BSE
Share Price
₹108.30
-5.00% today
EBITDA
−₹1.84 Cr
FY 2015-16
Net Profit
₹0.11 Cr
FY 2015-16
P/E (TTM)
54.4x
P/B 1.7x
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹50,000
Satisfied ₹6.24 Cr

About Starsource Multitrade Limited

Data last updated:

Starsource Multitrade Limited is a public limited company based in Kalyan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 1942 and has been in existence for over 84 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L46900MH1942PLC003556. Its shares are listed on BSE: 506365.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹1.5 Cr. It was formerly known as Chemo Pharma Laboratories Ltd. It is led by directors including Ruchit Mehta and Sarvagya Goel.

Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 Kumud Apartment Chs Limited Karnik Road Chikan Ghar Kalyan, Maharashtra, India – 421301.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹53 Lakh. For the same year it recorded a net profit of ₹2 Lakh (net margin 3.8%) and EBITDA of -₹11.87 Cr. The net worth stands at ₹1.29 Cr (down 90.2% YoY). Total assets are valued at ₹1.3 Cr (down 90.1% YoY).

The company is associated with 1 brand: The Chemo Pharma Laboratories. As per MCA filings, the company has open charges of ₹50,000 and satisfied charges of ₹6.24 Cr on record. Court records list 22 cases involving the company, including 8 filed by the company and 14 filed against it; 10 cases are pending. The company has 15 deals on record (15 market trades); the latest was in June 2026.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website thechemopharmalaboratoriesltd.com.

Company details

CIN L46900MH1942PLC003556
Registration Number 003556
Incorporation Date 17 August 1942
ROC Mumbai
Listing Status Listed (BSE: 506365)
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Starsource Multitrade has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L46900MH1942PLC003556, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L46900MH1942PLC003556Current
U99999MH1942PTC003556Previous
L99999MH1942PLC003556Previous

Contact details

Starsource Multitrade Limited's registered office is in Kalyan, Maharashtra.

  • Registered Address
    5 Kumud Apartment Chs Limited Karnik Road Chikan Ghar Kalyan, Maharashtra, India – 421301
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Starsource Multitrade Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Starsource Multitrade operates one associated brand: The Chemo Pharma Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Bulk drugs and pharmaceuticals have been developed since 1942.thechemopharmalaboratoriesltd.com

Business activity

The main business activity of Starsource Multitrade is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Starsource Multitrade Limited, buy the company report.

Financials of Starsource Multitrade Limited

FY 2025-26 filings available

Starsource Multitrade Limited reported revenue of ₹53 Lakh for FY 2025-26.

Financial Highlights

FY 2015-16 · Consolidated
Revenue
₹0.00 Cr
EBITDA
−₹1.84 Cr
Profit After Tax
₹0.11 Cr
Net Worth
₹3.67 Cr
Total Assets
₹3.79 Cr
Total Debt
Nil

Financial summary ₹ Cr

MetricsFY 2015-16
Income statement
Revenue0.00
EBITDA(1.84)
Profit before tax(1.35)
Net profit0.11
EPS (₹)0.00
Balance sheet
Total assets3.79
Net worth3.67
Total debt0.00
Cash & bank0.44
Net working capital2.12
Cash flow
Cash from operations(2.09)
Cash from investing2.15
Cash from financing0.00
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue0.530.000.000.000.000.000.00
EBITDA(11.87)(0.11)(0.18)(0.20)(0.40)(0.33)(0.49)
EBITDA margin-2239.6%------
Profit before tax(11.85)0.501.650.080.370.320.49
Net profit0.020.451.190.050.390.260.41
Net profit margin+3.8%------
EPS (₹)(79.03)2.288.000.323.731.672.77
Balance sheet
Total assets1.3013.1412.8011.6011.5510.9910.74
Net worth1.2913.1412.8011.6011.5510.9910.74
Total debt0.000.000.000.000.000.000.00
Cash & bank0.0110.626.116.066.1910.878.81
Net working capital1.2810.606.066.116.1910.908.69
Cash flow
Cash from operations(10.62)(0.28)0.72(0.68)(0.33)(0.41)4.83
Cash from investing0.0110.46(0.52)0.630.97(0.19)1.01
Cash from financing0.00(0.16)(0.15)(0.08)(2.12)1.960.00
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.070.000.000.530.000.000.000.00
Other income0.000.000.000.000.02(0.16)(0.15)0.63
Total expenses0.050.070.090.4311.830.020.020.02
EBITDA0.02(0.07)(0.09)0.10(11.83)(0.02)(0.02)(0.02)
EBITDA margin+28.6%--+18.9%----
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.02(0.07)(0.09)0.10(11.81)(0.18)(0.17)0.61
Tax0.000.000.000.000.000.160.000.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 22 Oct 2026
ParticularsFY 2015-16
Revenue0.00
Other income0.49
Total expenses1.84
Employee cost0.03
EBITDA(1.84)
Depreciation0.00
Interest0.00
Profit before tax(1.35)
Tax0.10
Net profit0.11
EPS (₹)0.00
ParticularsFY 2015-16
Equity & liabilities
Share capital1.50
Reserves & surplus2.17
Shareholders' funds (net worth)3.67
Minority interest0.00
Secured loans0.00
Unsecured loans0.00
Total debt0.00
Total liabilities3.79
Assets
Gross block0.09
Net block0.01
Capital work in progress0.00
Investments0.02
Inventories0.00
Sundry debtors0.00
Cash & bank balances0.44
Loans & advances1.75
Total current assets2.19
Total current liabilities0.07
Net working capital2.12
Total assets3.79
ParticularsFY 2015-16
Opening cash0.38
Net cash from operating activities(2.09)
Net cash from investing activities2.15
Net cash from financing activities0.00
Net change in cash0.06
Closing cash0.44
ParticularsFY 2015-16
Growth
PBT growth+9997.0%
Profitability & leverage
Return on capital employed0.0%
Return on net worth0.0%
Debt / equity0.00
Long-term debt / equity0.00
Interest cover0.00
Efficiency & per share
Fixed asset turnover0.00
Inventory turnover0.00
Debtors turnover0.00
EPS (₹)0.00
Dividend per share (₹)0.00
Book value per share (₹)24.49
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue0.070.000.000.530.000.000.000.00
Other income0.000.000.000.000.02(0.16)(0.15)0.63
Total expenses0.050.070.090.4311.830.020.020.02
EBITDA0.02(0.07)(0.09)0.10(11.83)(0.02)(0.02)(0.02)
EBITDA margin+28.6%--+18.9%----
Depreciation0.000.000.000.000.000.000.000.00
Interest0.000.000.000.000.000.000.000.00
Profit before tax0.02(0.07)(0.09)0.10(11.81)(0.18)(0.17)0.61
Tax0.000.000.000.000.000.160.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue0.530.000.000.000.000.000.00
Other income0.020.621.840.300.790.671.00
Total expenses12.400.110.180.200.400.330.49
Employee cost0.090.020.020.070.140.090.15
EBITDA(11.87)(0.11)(0.18)(0.20)(0.40)(0.33)(0.49)
EBITDA margin-2239.6%------
Depreciation0.000.010.010.010.020.020.02
Interest0.000.000.000.010.000.000.00
Profit before tax(11.85)0.501.650.080.370.320.49
Tax0.000.160.440.03(0.20)0.060.08
Net profit0.020.451.190.050.390.260.41
Net profit margin+3.8%------
EPS (₹)(79.03)2.288.000.323.731.672.77
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital1.501.501.501.501.501.501.50
Reserves & surplus(0.21)11.6411.3010.1010.059.499.24
Shareholders' funds (net worth)1.2913.1412.8011.6011.5510.9910.74
Secured loans0.000.000.000.000.000.000.00
Unsecured loans0.000.000.000.000.000.000.00
Total debt0.000.000.000.000.000.000.00
Total liabilities1.3013.1412.8011.6011.5510.9910.74
Assets
Gross block0.020.110.110.110.110.110.11
Net block0.000.010.010.020.040.050.08
Capital work in progress0.000.000.000.000.000.000.00
Investments0.010.014.403.032.940.040.02
Inventories0.000.000.000.000.000.000.00
Sundry debtors0.490.000.000.000.000.000.00
Cash & bank balances0.0110.626.116.066.1910.878.81
Loans & advances1.300.190.140.070.110.090.10
Total current assets1.8010.816.256.136.3010.968.91
Total current liabilities0.520.210.190.020.110.060.22
Net working capital1.2810.606.066.116.1910.908.69
Total assets1.3013.1412.8011.6011.5510.9910.74
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash10.620.610.560.692.170.812.97
Net cash from operating activities(10.62)(0.28)0.72(0.68)(0.33)(0.41)4.83
Net cash from investing activities0.0110.46(0.52)0.630.97(0.19)1.01
Net cash from financing activities0.00(0.16)(0.15)(0.08)(2.12)1.960.00
Net change in cash(10.61)10.020.05(0.13)(1.49)1.365.84
Closing cash0.0110.626.116.066.1910.878.81
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
EBITDA growth-+38.9%+10.0%+50.0%-21.2%+32.7%-
PBT growth--69.7%+1962.5%-78.4%+15.6%-34.7%+88.5%
Net income growth-95.6%-62.2%+2280.0%-87.2%+50.0%-36.6%-
EBITDA CAGR (3Y)+290.1%-35.0%-18.3%-25.8%-10.6%-1.0%+22.0%
Profitability & leverage
Net income margin-2235.9%------
Return on capital employed0.0%+5.2%+13.4%+0.8%+1.3%+2.9%+4.8%
Return on net worth0.0%+3.5%+9.8%+0.4%+3.4%+2.3%+4.0%
Debt / equity0.000.000.000.000.000.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.000.000.00-4.760.000.000.00
Efficiency & per share
Fixed asset turnover8.150.000.000.000.000.000.00
Inventory turnover0.000.000.000.000.000.000.00
Debtors turnover2.160.000.000.000.000.000.00
EPS (₹)(79.03)2.288.000.323.731.672.77
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)8.6087.6385.3577.3577.0373.3071.63

To see the full year-wise statements and ratios of Starsource Multitrade Limited, buy the company report.

Board of directors of Starsource Multitrade Limited

Starsource Multitrade has 5 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ruchit MehtaDirector01 Apr 20251 Years 6 MonthsCurrent
Sarvagya GoelDirector01 Apr 20251 Years 6 MonthsCurrent
Shilpy ChopraDirector01 Apr 20251 Years 6 MonthsCurrent
Utsav TrivediDirector01 Apr 20251 Years 6 MonthsCurrent
Simiran Ankleshwar TripathiDirector31 Dec 20241 Years 9 MonthsCurrent

Charges & borrowings

Open charges
₹50,000
Satisfied charges
₹6.24 Cr
Breakdown by lending institutions
Bank of Baroda₹5.35 Cr
The State Industrial Investmnet Corportion of Maharastra Lim₹0.38 Cr
Bank of Baroda .₹0.23 Cr
The State Industrial and Investment Corportion of Maharashtr₹0.07 Cr
The Bank of Baroda Ltd.₹0.05 Cr
Others₹0.16 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
05 Apr 199090150159Bank of Baroda₹4.25 CrSatisfied
01 Dec 198890150124Bank of Baroda .₹14.24 LakhSatisfied
24 Feb 198890150108Bank of Baroda₹20 LakhSatisfied
20 Jun 198790150097Bank of Baroda .₹8.6 LakhSatisfied
28 Jun 198390150032Bank of Baroda₹50 LakhSatisfied

To see the full charge records of Starsource Multitrade Limited, buy the company report.

Total charge records: 20 View all charges

Deals & funding

Starsource Multitrade Limited has 15 deals on record (15 market trades); the latest was in June 2026.

Total deals
15
Market trades
15

Deals on record (5 of 15)

WhenDealAmountParties
Jun 2026Market trade₹9 LakhBuyer: an individual
Seller: an individual
Apr 2025Market trade₹12.4 LakhBuyer: an individual
Mar 2025Market trade₹9.2 LakhBuyer: an individual
Dec 2024Market trade₹8.4 LakhBuyer: an individual
Seller: an individual
Sep 2024Market trade₹12.1 LakhBuyer: an individual
Seller: an individual

To see the full deal history of Starsource Multitrade Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Starsource Multitrade Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Starsource Multitrade Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Starsource Multitrade Limited has 21 board changes on record since 2009: 5 appointments and 16 cessations. The latest: Unnatti Nishant Jain ceased to be Company Secretary on 16 Apr 2025.

AGM
Starsource Multitrade Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Ceased
Unnatti Nishant Jain ceased to be Company Secretary.
Appointed
Ruchit Mehta was appointed as Director.
Appointed
Sarvagya Goel was appointed as Director.
Appointed
Shilpy Chopra was appointed as Director.
Appointed
Utsav Trivedi was appointed as Director.
Filing
Starsource Multitrade Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Simiran Ankleshwar Tripathi was appointed as Director.
Ceased
Nandkumar Pareek ceased to be Additional Director.
Ceased
Balkishan Devkaran Lohia ceased to be Director.
Ceased
Bhavin Suryakant Sheth ceased to be Additional Director.
Ceased
Shreeniwas Bansidhar Somani ceased to be Ceo(Kmp).

57 earlier events are in the company report.

Frequently asked questions

Starsource Multitrade is an active public limited company based in Kalyan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 1942 (84+ years old) and is registered under CIN L46900MH1942PLC003556. Listed on BSE: 506365.

Starsource Multitrade reported revenue of ₹53 Lakh for FY 2025-26 based on standalone financials.

Starsource Multitrade has 5 current directors:

The latest financial statements of Starsource Multitrade on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Starsource Multitrade is L46900MH1942PLC003556. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Starsource Multitrade is listed on BSE with code 506365.

Starsource Multitrade has 22 court cases on record: 8 filed by the company and 14 filed against it. 10 are pending. Most are in the high courts.

Starsource Multitrade was incorporated on 17 August 1942, making it 84+ years old. It is registered with the Registrar of Companies, Mumbai.

Starsource Multitrade has 15 deals on record (15 market trades); the latest was in June 2026.

Unnatti Nishant Jain ceased to be Company Secretary on 16 Apr 2025. Ruchit Mehta was appointed as Director on 01 Apr 2025. Sarvagya Goel was appointed as Director on 01 Apr 2025. Starsource Multitrade has 21 board changes on record in total.